-
-
-
-
-
-
-
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
-
-
-
-
-
-
-
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
-
-
-
-
-
-
-
FDA grants priority review to Bristol Myers Squibb Opdivo combo for lymphoma
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
-
-
-
-
-
-
-
Bristol Myers Squibb reports early CAR T therapy results for autoimmune diseases
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

